Ibogaine, the psychoactive alkaloid from the iboga plant, continues to build momentum as a promising intervention for complex conditions that often resist conventional therapies. In 2026, ibogaine treatment options are receiving heightened attention through groundbreaking research initiatives, state-level funding, and observational evidence from international clinics, particularly for interrupting addiction cycles, alleviating post-traumatic stress disorder (PTSD), […]